Sofia, Bulgaria, June 14, 2022 - According to art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, Sopharma AD notifies that on June 13, 2022 the Company bought 224 000 own shares representing 0.1662% of the share capital of the Company, at a total value of BGN 1 008 000,00 on the Bulgarian Stock Exchange, the average price per share was 4.500 BGN.

The total number of treasury shares after this transaction is 13 479 000, representing 9.999% of the share capital of the Company.

Sofia, Bulgaria, June 10, 2022 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD notifies that on the basis of Art. 187b of the Commercial Law and Art. 111 para. 5 and para. 6 of LPOS and in connection with a decision of the General Meeting of the company held on February 23, 2018 and a decision of the Board of Directors of June 3, 2022, “Sopharma” AD notifies that the company intends to buy its own shares in the restriction under Art. 111 para. 5 of LPOS, as follows:

Sofia, Bulgaria, June 7, 2022 - According to art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, Sopharma AD notifies that on June 6, 2022 the Company bought 200 00 own shares representing 0.1484% of the share capital of the Company, at a total value of BGN 200 000,00 on the Bulgarian Stock Exchange, the average price per share was 4.500 BGN.

The total number of treasury shares after this transaction is 13 255 000, representing 9.833% of the share capital of the Company.

Sofia, Bulgaria, June 6, 2022 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for May 2022 the Company recorded an increase in sales of 16% compared to the same month of the previous year, incl. 24% decrease in domestic sales and 77% increase in export sales.

For the five months since the beginning of the year the revenues from sales of products increase by 28%, incl. 35% increase of sales for the domestic market and 24% increase in export sales.